Stock Events

Stock Events

Lineage Cell Therapeutics (BT3.STU) Q2 2026 Earnings

12MayConfirmed

Q2 2026

-0.03

-0.02

-0.02

-0.02

Details

Expected EPS

-0.0170398

Actual EPS

-0.0255597

Surprise EPS

-0.01

Surprise Percent

+50%

Description

Lineage Cell Therapeutics (BT3.STU) has reported earnings of -0.0255597 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.